Below is Molecular Partners's Net Income - what it measures, how it is derived, and where it stands now. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Net Income
=
(Rev + Gain)
-
(Exp + Loss)
=
-61.65 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales. The Net Income metric for Molecular Partners reflects the latest filing period and is presented as context for further research.
The Net Loss history for Molecular Partners AG traces this metric's path over time. Comparing recent readings against the long-term range helps investors gauge whether Molecular Partners's current level is normal, elevated, or below its own historical baseline.
Latest Molecular Partners' Net Loss Growth Pattern
Molecular Partners AG's Net Loss is charted below. Net income is one of the most important fundamental items in finance. It plays a large role in Molecular Partners financial statement analysis. It represents the amount of money remaining after all of Molecular Partners AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The goal is to see whether Molecular Partners' Net Loss is heading in a new direction or staying on course.
Understanding the correlations between Molecular Partners' financial accounts, including Net Income, is fundamental to building accurate financial models for Molecular Partners. Because Molecular Partners' key financial indicators are all interdependent within its reporting framework, examining their correlations is more efficient than reviewing each statement independently.
Fiscal trend analysis indicates Accumulated Other Comprehensive Income is set to increase significantly relative to last year. Molecular Partners entered the current period with Accumulated Other Comprehensive Income of 0.00 on the books.
Based on the recorded statements, Molecular Partners AG reported net income of -61.65 Million. Relative to the Biotechnology sector, this is 118.06% below, while the Health Care industry average sits 188.02% above. Across all Switzerland stocks, the average net income is 110.8% above Molecular Partners's level.
Fundamental Drivers Relationships
Cross-company financial ratios help determine Molecular Partners's valuation standing. You can analyze the relationship between different fundamental ratios across Molecular Partners competition to find correlations between indicators driving Molecular Partners's intrinsic value. More Info.
Molecular Partners AG is rated below average for net income across the peer group. It is rated below average for return on asset across the peer group . Net Loss is developing negatively compared to historical levels. Year-ago financials show Molecular Partners with Net Loss of -61.65 Million. Comparative pricing ratios evaluate Molecular Partners against peer standards.
Net Income Peer Comparison
Stock peer comparison on Net Income is a widely used and accepted method for evaluating Molecular Partners relative to its direct and indirect competitors. Analyzing Molecular Partners' Net Income against that of similar stocks can help detect undervalued opportunities or identify better portfolio.
Molecular Partners is currently under evaluation for net income across the peer group.
Molecular Partners reports ROE of -55.55%, debt-to-equity of 0.02. Molecular Partners's operating framework provides insight into margin behavior and earnings persistence. Profitability regime consistency underpins valuation stability over time. For this reporting period, Molecular Partners reflects EPS loss of 1.65, current ratio of 14.37, debt-to-equity of 0.02.
This section for Molecular Partners AG is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.